Roberts SM, Bezinover DS, Janicki PK. Cancer Management and Research. 2012; 4: 67–73.
On the first page of the paper the incorrect DOI has been displayed. The correct DOI is: 10.2147/CMAR.S15545.
. 2016 Jun 28;8:83. doi: 10.2147/CMAR.S115369
Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy [Erratum]
Collection date 2016.
© 2016 Roberts et al. This work is published and licensed by Dove Medical Press Limited
The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
PMCID: PMC4930224 PMID: 27390532
This corrects the article "Reappraisal of the role of dolasetron in prevention and treatment of
nausea and vomiting associated with surgery or chemotherapy" in volume 4 on page 67.